Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|---|
Filter | GSE210051 | Aug 01, 2022 | |||||||
GSM6415849 |
23809 primary tumour immunotherapy treated [SJ41-1]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 | |||
GSM6415850 |
23810 primary tumour [SJ41-2]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 | |||
GSM6415851 |
23811 primary tumour [SJ41-3]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 | |||
GSM6415852 |
23812 primary tumour [SJ41-4]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 | |||
GSM6415853 |
23813 primary tumour [SJ41-5]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 | |||
GSM6415854 |
23819 primary tumour [SJ41-6]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 | |||
GSM6415855 |
23822 primary tumour [SJ41-7]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 | |||
GSM6415856 |
23827 primary tumour [SJ41-9]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 | |||
GSM6415857 |
23833 primary tumour [SJ41-10]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 | |||
GSM6415858 |
23853 primary tumour [SJ41-11]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 | |||
GSM6415859 |
23854 primary tumour [SJ41-12]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 | |||
GSM6415860 |
23809 Lungs immunotherapy treated [SJ41-13]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 | |||
GSM6415861 |
23810 Lungs immunotherapy treated [SJ41-14]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 | |||
GSM6415862 |
23811 Lungs immunotherapy treated [SJ41-15]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 | |||
GSM6415863 |
23812 Lungs control treated [SJ41-16]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 | |||
GSM6415864 |
26813 lungs control treated [SJ41-17]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 | |||
GSM6415865 |
26819 lungs control treated [SJ41-18]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 | |||
GSM6415866 |
26822 lungs control treated [SJ41-19]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 | |||
GSM6415867 |
26823 lungs control treated [SJ41-20]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 | |||
GSM6415868 |
26827 lungs control treated [SJ41-21]
|
SRA | 1 |
|
Alexander Swarbrick | Aug 01, 2022 |